Suchergebnisse - "Parivar, Kourosh"

PubPharm (35)

1

An Investigation in the Comparability of the Exposure and Recommended Dose of Selected Pfizer Drugs in East Asian Countries : Is Mutual Usage of Clinical Data Among East Asian Countries Feasible?

enthalten in: Journal of clinical pharmacology | 2024

von Wang, D. | Yu, Y. | Fukuhara, K. | +3

2

An Investigation in the Comparability of the Exposure and Recommended Dose of Selected Pfizer Drugs in East Asian Countries : Is Mutual Usage of Clinical Data Among East Asian Countries Feasible?

enthalten in: The Journal of Clinical Pharmacology | 2024

von Wang, D. | Yu, Y. | Fukuhara, K. | +3

3

Optimizing benefit/risk in oncology : Review of post-marketing dose optimization and reflections on the road ahead

enthalten in: Critical reviews in oncology/hematology | 2023

von Soltantabar, P. | Lon, H. | Parivar, K. | +2

4

Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing Recommendations

enthalten in: Clinical pharmacology and therapeutics | 2022

von Yang, D. | Alhadab, A. | Parivar, K. | +2

5

Tumor growth inhibition modeling to support the starting dose for dacomitinib

enthalten in: CPT: pharmacometrics & systems pharmacology | 2022

von Fostvedt, L. | Nickens, D. | Tan, W. | +1

6

Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing Recommendations

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Yang, D. | Alhadab, A. | Parivar, K. | +2

7

Tumor growth inhibition modeling to support the starting dose for dacomitinib

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2022

von Fostvedt, L. | Nickens, D. | Tan, W. | +1

8

Discordance Between Child-Pugh and National Cancer Institute Classifications for Hepatic Dysfunction : Implications on Dosing Recommendations for Oncology Compounds

enthalten in: Journal of clinical pharmacology | 2021

von Elmeliegy, M. | Yang, D. | Salama, E. | +2

9

Discordance Between Child‐Pugh and National Cancer Institute Classifications for Hepatic Dysfunction : Implications on Dosing Recommendations for Oncology Compounds

enthalten in: The Journal of Clinical Pharmacology | 2021

von Elmeliegy, M. | Yang, D. | Salama, E. | +2

10

Evaluation of the potential effect of dacomitinib, an EGFR tyrosine kinase inhibitor, on ECG parameters in patients with advanced non-small cell lung cancer

enthalten in: Investigational new drugs | 2020

von Tan, W. | Giri, N. | Quinn, S. | +2